Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July - Forbes

Anthony Fauci said the Phase 3 trial of Moderna’s experimental COVID-19 vaccine will begin in July and include study of 30,000 patients who will be as young as 18 and include elderly Americans as well.

In an interview Tuesday with the editor of JAMA, Fauci said the trial will include primarily U.S.

sites, but also include international sites enrolling 30,000 individuals in a “randomized placebo” controlled trial of Moderna’s vaccine against the Coronavirus strain Covid-19.

Moderna last week said it began enrolling 600 healthy participants in a phase 2 clinical trial testing mRNA-1273, the company’s vaccine against the virus that causes Covid-19.

But Fauci confirmed Tuesday the work to begin a much larger phase 3 trial are well underway and will begin early next month.

“We are going to start manufacturing doses of the vaccines way before we even know the vaccine works,” Fauci said of the manufacturing process.

I've written about health care for three decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the.

I've written about health care for three decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the Hawkeye state talking health reform and the economy